Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonaventure

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
British Journal of Pharmacology|May 14, 2025
Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonistBrian Lord, Sirak Simavorian, Ian Fraser, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2009
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the ratChristine Dugovic, Jonathan E Shelton, Leah E Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y₂ receptorDevin M Swanson, Victoria D Wong, Jill A Jablonowski, et al.
Psychopharmacology|November 19, 2010
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsRuggero Galici, Amir H Rezvani, Leah Aluisio, et al.
European Journal of Medicinal Chemistry|July 7, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonistsDevin M Swanson, Chandra R Shah, Brian Lord, et al.
Psychopharmacology|December 3, 2009
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptorJames R Shoblock, Natalie Welty, Diane Nepomuceno, et al.
European Journal of Pharmacology|September 4, 2007
Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitorAnn J Barbier, Leah Aluisio, Brian Lord, et al.
Molecular Pharmacology|September 10, 2015
GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-PhenylalanineChanglu Liu, Pascal Bonaventure, Grace Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitorsKiev S Ly, Michael A Letavic, John M Keith, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2015
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of InsomniaPascal Bonaventure, Jonathan Shelton, Sujin Yun, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Pharmacology|May 14, 2025
Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonistBrian Lord, Sirak Simavorian, Ian Fraser, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2009
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the ratChristine Dugovic, Jonathan E Shelton, Leah E Aluisio, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y₂ receptorDevin M Swanson, Victoria D Wong, Jill A Jablonowski, et al.
Psychopharmacology|November 19, 2010
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsRuggero Galici, Amir H Rezvani, Leah Aluisio, et al.
European Journal of Medicinal Chemistry|July 7, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonistsDevin M Swanson, Chandra R Shah, Brian Lord, et al.
Psychopharmacology|December 3, 2009
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptorJames R Shoblock, Natalie Welty, Diane Nepomuceno, et al.
European Journal of Pharmacology|September 4, 2007
Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitorAnn J Barbier, Leah Aluisio, Brian Lord, et al.
Molecular Pharmacology|September 10, 2015
GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-PhenylalanineChanglu Liu, Pascal Bonaventure, Grace Lee, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitorsKiev S Ly, Michael A Letavic, John M Keith, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2015
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of InsomniaPascal Bonaventure, Jonathan Shelton, Sujin Yun, et al.
Pageof 10